Moderator: Joshua E. Heller, MD
262. Do large increases in disc space height have consequences after ACDF?
Bryce Basques, MD, MHS1; Jannat M. Khan, MD2; Michael T. Nolte, MD3; Philip Louie, MD1; Arash Sayari, BS, MD1; Michael N. Iloanya, MD4; Edward J. Goldberg, MD5; Howard S. An, MD6
1Rush University Medical Center, Chicago, IL, US; 2Midwest Orthopaedics at Rush University, Chicago, IL, US; 3Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, US; 4Chicago, IL, US; 5Midwest Orthopedics At Rush, Chicago, IL, US; 6Rush University Medical Center, Department of Orthopedic Surgery, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
263. Insulin dependence and 30-day outcomes following posterior cervical fusions: an analysis of the ACS-NSQIP database
Azeem T. Malik, MBBS1; Jeremy A. Jones, MD2; Safdar N. Khan, MD1; Elizabeth Yu, MD1; Jeffery Kim, MD1
1The Ohio State University Wexner Medical Center, Columbus, OH, US; 2Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
264. Economic impact of revision operations for adjacent segment disease of the cervical spine
John C. Bonano, MD1; Shane Burch, MD2; Sigurd H. Berven, MD3; Vedat Deviren, MD2; Bobby Tay, MD2; Alexander A. Theologis, MD4
1Los Altos, CA, US; 2University of California San Francisco, San Francisco, CA, US; 3UCSF, Department of Orthopaedic Surgery, San Francisco, CA, US; 4UCSF Spine Center, San Francisco, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
265. Novel C1-2 loop-suture technique for securing interlaminar bone graft during atlanto-axial arthrodesis: surgical technique and outcomes
Robert Koffie, MD, PhD1; Alexandra M. Giantini Larsen, BS2; Benjamin L. Grannan, MD2; Muhamed Hadzipasic, MD, PhD1; Vijay Yanamadala, MD3; Ganesh M. Shankar, MD, PhD2; Laura A. Van Beaver, BS4; John H. Shin, MD1
1Massachusetts General Hospital, Boston, MA, US; 2Boston, MA, US; 3Stamford, CT, US; 4Simches Research Center, Boston, MA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
2019 Resident and Fellow Research Award Winner
266. Angiotensin-II type-1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) display opposite fusion rates in cervical spine
Alexander Perdomo-Pantoja, MD1; Feras Shamoun, BS2; Wataru Ishida, MD3; Seba Ramhmdani, MD2; Christina Holmes, PhD2; Ethan Cottrill, MS2; Ali Bydon, MD3; Sheng-fu L. Lo, MD, MHS1; Nicholas Theodore, MD2; Timothy F. Witham, MD, FACS1
1The Johns Hopkins University School of Medicine, Baltimore, MD, US; 2Baltimore, US; 3Johns Hopkins Hospital, Baltimore, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
267. One stage atlantoaxial pedicle screw fixation for unstable atlas burst fracture
Wei-yu Jiang, MD
Ningbo, China
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
268. Neuroanatomical categorization of motor evoked potential (MEP) alerts during cervical spine surgery and associated risk for new neurologic deficit (NND): retrospective analysis of 40,919 procedures
Bryan Wilent, PhD, DABNM1; Thomas J. Epplin-Zapf, MS, MA, CNIM2; Eric A. Tesdahl, PhD1; Mitali Bose, CNIM, MS2; Jeffrey Cohen, MD, PhD3; Anthony K. Sestokas, PhD1
1SpecialtyCare, Nashville, TN, US; 2SpecialtyCare, Brentwood, TN, US; 3SpecaltyCare, Scottsdale, AZ, US>
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion